IRIS
PETRUCCI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 756
AS - Asia 532
EU - Europa 330
SA - Sud America 66
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 10
Totale 1.755
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 678
IT - Italia 264
CN - Cina 146
BD - Bangladesh 130
SG - Singapore 116
HK - Hong Kong 77
BR - Brasile 42
EE - Estonia 40
CA - Canada 36
MX - Messico 16
VN - Vietnam 14
GT - Guatemala 10
IN - India 7
AR - Argentina 6
PK - Pakistan 6
SA - Arabia Saudita 6
CR - Costa Rica 5
PH - Filippine 5
TR - Turchia 5
ES - Italia 4
FR - Francia 4
ID - Indonesia 4
NP - Nepal 4
VE - Venezuela 4
CO - Colombia 3
DE - Germania 3
EC - Ecuador 3
GB - Regno Unito 3
MY - Malesia 3
PE - Perù 3
CL - Cile 2
MA - Marocco 2
NI - Nicaragua 2
RU - Federazione Russa 2
SV - El Salvador 2
UA - Ucraina 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AW - Aruba 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NL - Olanda 1
NO - Norvegia 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 1.694
Salva come PNG Salva come JPEG
Città #
San Jose 246
Ashburn 134
Hong Kong 76
Council Bluffs 72
Singapore 68
Beijing 64
Rome 46
Tallinn 40
Milan 31
Santa Clara 23
Naples 18
Figino 15
New York 15
Dallas 10
Guatemala City 10
Mexico City 10
Phoenix 10
Chicago 8
São Paulo 8
Los Angeles 7
Cagliari 6
Florence 6
Toronto 6
Turin 6
Hanoi 5
Palermo 5
Bari 4
Brescia 4
Buffalo 4
Ho Chi Minh City 4
Houston 4
Modena 4
Montreal 4
San José 4
Verona 4
Bologna 3
Calgary 3
Catania 3
Denver 3
Istanbul 3
Jeddah 3
Prato 3
Atlanta 2
Buenos Aires 2
Charlotte 2
Cincinnati 2
Dresden 2
Edmonton 2
Genoa 2
Kuala Lumpur 2
Lahore 2
Los Alamitos 2
Managua 2
Montevideo 2
Newark 2
North Vancouver 2
Padua 2
Pescara 2
Portoviejo 2
Queens 2
Rabat 2
Rio de Janeiro 2
Riyadh 2
Sacramento 2
Salvador 2
San Pedro 2
San Salvador 2
Selma 2
St Louis 2
Taranto 2
Abuja 1
Addis Ababa 1
Afragola 1
Ahrntal 1
Aire-sur-la-Lys 1
Al Ain City 1
Albany 1
Amiens 1
Ancona 1
Ardmore 1
Arequipa 1
Arezzo 1
Asheboro 1
Aversa 1
Baguio City 1
Bakersfield 1
Bandera 1
Bandung 1
Barletta 1
Barra Bonita 1
Beamsville 1
Belize City 1
Belém 1
Benito Juarez 1
Bergamo 1
Bexley 1
Bhadrapur 1
Bloomfield Hills 1
Boston 1
Bracey 1
Totale 1.088
Salva come PNG Salva come JPEG
Nome #
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 113
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 78
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 74
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 68
Stability of the thromboxane B2 biomarker of aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 63
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 57
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 46
Effect of Low-dose and Standard-dose Aspirin on PGE 2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial 41
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 36
Tumorigenic Potential of Olfactory Bulb-Derived Human Adult Neural Stem Cells Associates with Activation of TERT and NOTCH1 34
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 32
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 32
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 31
Very-Low-Dose Twice-Daily Aspirin Maintains Platelet Inhibition and Improves Hemostasis during Dual-Antiplatelet Therapy for Acute Coronary Syndrome 29
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation 28
Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial 27
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 27
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note 26
Long-term pharmacodynamic and clinical effects of twice-daily low-dose aspirin in patients with essential thrombocythemia: results from the ARES randomized phase-2 trial 26
Mesenchymal differentiation of glioblastoma stem cells 26
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 26
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 25
Telomerase inhibition impairs tumor growth in glioblastoma xenografts 25
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 24
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 24
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 23
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 23
the Contribution of COX-1 and COX-2 to platelet activation in Essential Thrombocythemia: a clinical paradigm of aspirin-resistant thromboxane biosynthesis 22
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 22
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 21
Aspirin, stroke and drug-drug interactions 20
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 20
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 20
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 19
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 19
Poor responsiveness to low-dose aspirin contributes to persistent in vivo platelet activation in polycythemia vera 19
In Vivo Platelet Activation In Impaired Glucose Tolerance And During Progression Of Type 2 Diabetes: A Cross-sectional And Longitudinal Study 19
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 18
. Effect of low-dose rivaroxaban with low-dose aspirin vs. low-dose aspirin on platelet and oxidative biomarkers: a randomized study in diabetes patients with stable peripheral or coronary artery disease 18
Mesenchymal differentiation of glioblastoma stem cells 18
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 18
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 18
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 18
Variability in the recovery rate of platelet cyclooxygenase activity during chronic therapy with low-dose aspirin in type 2 diabetes 18
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 18
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 17
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 17
Tumorigenic potential of olfactory bulb derived human adult neural stem cells associates whit activation of TERT and NOTCH1. 17
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 16
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial 16
Distinct expression of cyclooxygenase-1 and -2 in the human thymus 16
Impact of COX-2 deletion on platelet and megakaryocyte phenotypes 16
Von Willebrand factor levels in polycythemia vera are not reduced and can be predicted by erythrocyte counts 15
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 15
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 14
Farmaci Antipiastrinici 14
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 14
Platelet Thromboxane Inhibition by Low-Dose Aspirin in Polycythemia Vera: Ex Vivo and In Vivo Measurements and In Silico Simulation. 14
Platelet and megakaryocyte phenotypes of COX-2 deletion 14
In Vivo Platelet Activation And Aspirin Responsiveness In Type 1 Diabetes Mellitus 13
Deletion of p66Shc gene restores endothelial function in a mouse model of obesity and insulin resistance 13
Pathophysiology of Thrombosis in Peripheral Artery Disease 13
Effect of cyclooxygenase-2 (COX-2) delection on megakaryopoiesis and peripheral platelet phenotype 13
VON WILLEBRAND FACTOR CHANGES IN ESSENTIAL THROMBOCYTHEMIA. ITS ROLE IN THROMBO-HAEMORRHAGIC COMPLICATIONS. 13
Kinetics of 24-hour recovery of platelet TXA2 production: a methodological approach to describe and understand variability in low-dose aspirin response 12
Variable antiplatelet response to thyenopiridines: should we use lab tests? 12
The lifespan determinant p66sch drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 11
prostaglandin E2 and EP3 activation potentiate human platelet responsiveness 11
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation 10
Insulin Resistant Mice Lacking p66Shc Gene are Protected Against Endothelial Dysfunction 10
Totale 1.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202581 0 0 0 40 0 0 1 9 0 0 17 14
2025/20261.025 8 1 18 33 56 54 98 97 356 101 139 64
2026/2027649 163 35 178 273 0 0 0 0 0 0 0 0
Totale 1.755